4. Segment Information and Concentrations

9 Months Ended

Mar. 31, 2013

Segment Reporting [Abstract]

Segment Information and Concentrations

The Company views its operations as three segments:  the manufacture and marketing of standard benchtop laboratory equipment for research in university, hospital and industrial laboratories sold primarily through laboratory equipment distributors (ABenchtop Laboratory Equipment@), the manufacture and marketing of custom-made catalyst research instruments for universities, government laboratories, and chemical and petrochemical companies sold on a direct basis (ACatalyst Research Instruments@) and the marketing and production of bioprocessing systems for laboratory research in the biotechnology industry sold directly to customers and through distributors (“Bioprocessing Systems”).

Segment information is reported as follows:

	Benchtop Laboratory Equipment		Catalyst Research Instruments		Bioprocessing Systems			Corporate and Other		Consolidated
Three months ended March 31, 2013
Net Sales	$	1,229,800	$	360,600	$	35,700		$	-	$	1,626,100
Foreign Sales		645,300		107,300		-			-		752,600
Profit (Loss)		243,300		3,600		(41,700	)		-		205,200
Assets		2,719,500		1,932,600		904,600			916,800		6,473,500
Long-Lived Asset Expenditures		1,700		1,200		-			-		2,900
Depreciation and Amortization		10,700		8,700		24,000			-		43,400

	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Three months ended March 31, 2012
Net Sales	$	1,025,300	$	418,300		$	75,900		$	-		$	1,519,500
Foreign Sales		613,900		405,900			3,600			-			1,023,400
Profit (Loss)		80,700		(76,000	)		(16,300	)		(4,100	)		(15,700	)
Assets		2,446,300		1,239,700			842,700			1,492,500			6,021,200
Long-Lived Asset Expenditures		7,500		-			-			-			7,500
Depreciation and Amortization		12,500		5,900			24,000			-			42,400

Approximately 71% and 62% of net sales of benchtop laboratory equipment for the three month periods ended March 31, 2013 and 2012, respectively, were derived from the Company=s main product, the Vortex-Genie 2 mixer, excluding accessories.

Two benchtop laboratory equipment customers accounted for approximately 27% of the segment=s net sales for each of the three month periods ended March 31, 2013 and 2012 (20% and 18% of total net sales, respectively, for the periods).

Sales of catalyst research instruments are generally pursuant to large orders averaging more than $100,000 per order to a limited numbers of customers.  Sales to three customers in the three months ended March 31, 2013 and two different customers in the three months ended March 31, 2012, accounted respectively for 92% of the segment=s net sales for each of the periods (20% and 25% of total net sales for the respective periods).

	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other		Consolidated
Nine months ended March 31, 2013
Net Sales	$	3,459,500	$	1,309,700		$	85,500		$	-	$	4,854,700
Foreign Sales		2,014,900		626,400			-			-		2,641,300
Profit (Loss)		518,100		(62,500	)		(147,600	)		-		308,000
Assets		2,719,500		1,932,600			904,600			916,800		6,473,500
Long-Lived Asset Expenditures		10,900		19,300			-			-		30,200
Depreciation and Amortization		33,300		27,200			71,900			-		132,400

	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Nine months ended March 31, 2012
Net Sales	$	3,208,900	$	973,200		$	75,900		$	-		$	4,258,000
Foreign Sales		1,977,700		527,000			3,600			-			2,508,300
Profit (Loss)		341,300		(252,400	)		(48,600	)		(62,300	)		(22,000	)
Assets		2,446,300		1,239,700			842,700			1,492,500			6,021,200
Long-Lived Asset Expenditures		21,500		49,500			876,000			-			947,000
Depreciation and Amortization		36,700		68,900			36,000			-			141,600

Approximately 69% and 63% of net sales of benchtop laboratory equipment for the nine month periods ended March 31, 2013 and 2012, respectively, were derived from the Company=s main product, the Vortex-Genie 2 mixer, excluding accessories.

Two benchtop laboratory equipment customers, accounted for approximately 24% and 26% of the segment=s net sales (17% and 24% of total net sales) for the nine month periods ended March 31, 2013 and 2012, respectively.

Sales of catalyst research instruments to three customers in the nine months ended March 31, 2013 and to three other customers in the nine months ended March 31, 2012 accounted for approximately 49% and 65% of that segment=s net sales (13% and 15% of total net sales) for the respective nine month periods.

The Company=s foreign sales are principally made to customers in Europe and Asia.